| |
 |
|
Class Information
Number: 514/573
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai > Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) > Cyclic carboxylic acid containing three to five carbons or cyclic percarboxylic acid containing three to five carbons or salt thereof > Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.)
Description: Subject matter wherein the ring is cyclopentyl or cyclopentene.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7608642 |
Wound and skin care compositions |
Oct. 27, 2009 |
| 7560489 |
Stabilized prostaglandin E composition |
Jul. 14, 2009 |
| 7553874 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Jun. 30, 2009 |
| 7553875 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Jun. 30, 2009 |
| 7550508 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Jun. 23, 2009 |
| 7541382 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Jun. 2, 2009 |
| 7517912 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Apr. 14, 2009 |
| 7514474 |
Prostaglandin analog compositions and methods to treat epithelial-related conditions |
Apr. 7, 2009 |
| 7498360 |
Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss |
Mar. 3, 2009 |
| 7452556 |
Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride |
Nov. 18, 2008 |
| 7405222 |
Methods and compositions for treatment of erectile dysfunction |
Jul. 29, 2008 |
| 7405240 |
Substituted cyclopentanes or cyclopentanones as therapeutic agents |
Jul. 29, 2008 |
| 7381748 |
Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase |
Jun. 3, 2008 |
| 7358226 |
Ultrasonic concentration of drug delivery capsules |
Apr. 15, 2008 |
| 7318930 |
Control methods for boring bark beetles |
Jan. 15, 2008 |
| 7258850 |
Methods and compositions for treating erectile dysfunction |
Aug. 21, 2007 |
| 7241746 |
Method and composition for treating periodontal disease |
Jul. 10, 2007 |
| 7223746 |
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
May. 29, 2007 |
| RE39609 |
8-iso-prostaglandins for glaucoma therapy |
May. 1, 2007 |
| 7169580 |
Protein having PGE2 synthase activity and use thereof |
Jan. 30, 2007 |
| 7151094 |
Topical administration of amifostine and related compounds |
Dec. 19, 2006 |
| 7132453 |
Method of using prostacyclin to treat respiratory syncytial virus infections |
Nov. 7, 2006 |
| 7129272 |
Apoptosis inhibitor |
Oct. 31, 2006 |
| 7105571 |
Prostaglandin compositions and methods of treatment for male erectile dysfunction |
Sep. 12, 2006 |
| 7064148 |
Chloride channel opener |
Jun. 20, 2006 |
| 6992093 |
Method of inhibiting lipofibroblast to myofibroblast transdifferentiation |
Jan. 31, 2006 |
| 6982283 |
Method for treating drug-induced constipation |
Jan. 3, 2006 |
| 6982097 |
Biocidal compositions and methods of using same |
Jan. 3, 2006 |
| 6956057 |
EP4 agonists as agents for lowering intraocular pressure |
Oct. 18, 2005 |
| 6956056 |
Method for providing a cathartic effect |
Oct. 18, 2005 |
| 6949526 |
Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient |
Sep. 27, 2005 |
| 6911473 |
Detectable agent for wood treatment and method for its detection |
Jun. 28, 2005 |
| 6897239 |
Use of misoprostol and/or metabolites of misoprostol for treating sexual dysfunction in women |
May. 24, 2005 |
| 6875787 |
10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
Apr. 5, 2005 |
| 6841574 |
Topical stabilized prostaglandin E compound dosage forms |
Jan. 11, 2005 |
| 6825232 |
Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
Nov. 30, 2004 |
| 6825234 |
Compositions and methods for amelioration of human female sexual dysfunction |
Nov. 30, 2004 |
| 6794413 |
Compounds and related methods for inhibition of .gamma.-aminobutyric acid aminotransferase |
Sep. 21, 2004 |
| 6770675 |
Compositions and methods for reducing ocular hypertension |
Aug. 3, 2004 |
| 6756407 |
Method and compositions for the treatment or amelioration of female sexual dysfunction |
Jun. 29, 2004 |
| 6756033 |
Method for delivering benzindene prostaglandins by inhalation |
Jun. 29, 2004 |
| 6747063 |
Combination therapy for treatment of erectile dysfunction |
Jun. 8, 2004 |
| 6723748 |
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Apr. 20, 2004 |
| 6716876 |
Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
Apr. 6, 2004 |
| 6710081 |
Erection insufficiency remedies |
Mar. 23, 2004 |
| 6703423 |
Inhibition of TNF.alpha.-initiated neutrophil response |
Mar. 9, 2004 |
| 6693135 |
Prostaglandin compositions and methods of treatment for male erectile dysfunction |
Feb. 17, 2004 |
| 6686388 |
Regulators of the hedgehog pathway, compositions and uses related thereto |
Feb. 3, 2004 |
| 6680337 |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
Jan. 20, 2004 |
| 6680339 |
15-fluoro prostaglandins as ocular hypotensives |
Jan. 20, 2004 |
|
|
|
